In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
What a cardiologist should know about heart failure with comorbidities
Session

Event : ESC Congress 2016

Topic : Chronic Heart Failure – Pathophysiology and Mechanisms

  • Session type : Symposium
  • Date : 30 August 2016
  • Time : 14:00 - 15:30
  • Organised by Heart Failure Assciation of the ESC

4 presentations in this session

Differences between preserved and reduced ejection fraction

Event : ESC Congress 2016

  • Session : What a cardiologist should know about heart failure with comorbidities
  • Speaker : A Ahmed (Washington,US)
  • Organised by Heart Failure Assciation of the ESC

Biomarkers and diagnostic devices in patients with comorbidities

Event : ESC Congress 2016

  • Session : What a cardiologist should know about heart failure with comorbidities
  • Speaker : R De Boer (Groningen,NL)
  • Organised by Heart Failure Assciation of the ESC

Management of heart failure with worsening renal function

Event : ESC Congress 2016

  • Session : What a cardiologist should know about heart failure with comorbidities
  • Speaker : M Metra (Brescia,IT)
  • Organised by Heart Failure Assciation of the ESC

Heart failure and diabetes

Event : ESC Congress 2016

  • Session : What a cardiologist should know about heart failure with comorbidities
  • Speaker : S Anker (Berlin,DE)
  • Organised by Heart Failure Assciation of the ESC

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are